Skip to Content
Søk Menu
2024

EADV | European Academy of Dermatology and Venereology

EADV 2025

Vi dekker EADV 2025 når det går av stabelen 17.–21. september.

Her vil du kunne lese artikler og se MEDtalks om de nyeste forskningsresultatene innen dermatologi.

EADV 2024

Lone Skov

EADV 2024 – Still Unanswered Questions about Psoriasis and Psoriasis Treatment

/ Lone Skov
EADV24PsoriasisPsoriasisartrit Play the Video

Gå ikke glipp av det nyeste

Registrer deg og få nye artikler, MEDtalks og tidsskrifter direkte til din innboks.

Få adgang
Annarita Antelmi

A Large Proportion of Patients with Prurigo Nodularis Receive Several Different Treatment Combinations and Switches and a High Number of Healthcare Visits

/ Annarita Antelmi
EADV24 Play the Video

Deucravacitinib, A New Oral Option for Patients with Moderate to Severe Psoriasis

/ Sofie Pohl
Psoriasis
Viola Ikebudu Adaeze

Diagnostic Challenges for Immunobullous Disorders in Elderly Patients in Lagos

/ Viola Ikebudu Adaeze
EADV24 Play the Video
Giovanni Damiani

A lot of Factors Increase the Comorbidity at Atopic Dermatitis

/ Giovanni Damiani
Atopisk dermatittEADV24 Play the Video
Sascha D. W. Stave

Safety Is One of the Main Drivers for Atopic Dermatitis Patient Preferences of Treatment

/ Sascha D. W. Stave
Atopisk dermatittEADV24 Play the Video
Andrew Blauvelt

LBA: Probably the Best in Class for Treatment of Plaque Psoriasis

/ Andrew Blauvelt
EADV24Psoriasis Play the Video
Thrasyvoulos Tzellos

AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data

/ Thrasyvoulos Tzellos
Atopisk dermatittEADV24 Play the Video
Christopher Willy Schwarz

Non-Medical Switches of Biosimilar in Psoriasis Treatment Appears Safe

/ Christopher Willy Schwarz
EADV24Psoriasis Play the Video
Load more

EADV 2023

Severe Alopecia Areata: JAK-Inhibitor Increases Hair Regrowth and Improve Quality of Life

/ Dermatologi / Bianca Maria Piraccini

Personalized Medicine on the Horizon for Atopic Dermatitis

/ Dermatologi / Marjolein de Bruin-Weller

Risk Factors for JAK-Inhibitor Treatment in Atopic Dermatitis

/ Dermatologi / Ida Vittrup

New Treatments for Atopic Dermatitis to Come

/ Dermatologi / Stephan Weidinger

Concentration of Ixekizumab Paving the Way Towards Personalized Therapy in Psoriasis

/ Dermatologi / Lisa Schots

New Insights into Type 2 Inflammation in Atopic Dermatitis

/ Dermatologi / Stephan Weidinger
Se oversigt

Deucravacitinib: Significantly Improved Symptoms and Signs of Psoriasis in Patients with Psoriasis

/ Dermatologi / Kim Papp

New Oral Drug Sotyktu for Plaque Psoriasis Patients Demonstrates Promising Results with Favorable Safety Profile

/ Dermatologi / Enikö Sonkoly

AD: New Knowledge About Type 2 Inflammation and Skin Barrier Deficiency

/ Dermatologi / Stephan Weidinger

An Overview of the Exciting News From EADV 2023

/ Dermatologi / Enikö Sonkoly

New and Promising Treatments for Psoriasis

/ Dermatologi / Andreas Pinter

IL-17 Targeted Drugs Signal Hope for Hidradenitis Suppurativa Patients

/ Dermatologi / Thrasyvoulos Tzellos

Latest Advancements in the Management of Psoriasis: Insights From EADV 2023

/ Dermatologi / Kristian Reich

Deucravacitinib in Psoriasis: Three-Year Safety and Efficacy Results

/ Dermatologi / April Armstrong

Promising Result for Patients with Prurigo Nodularis: Targeting IL-4 and IL-13 Signaling

/ Dermatologi / Martin Metz

Alopecia Areata: Are New Treatments a Real Breakthrough? 

/ Dermatologi / BestPractice Nordic

Early Detection and Prevention of Psoriatic Arthritis

/ Dermatologi / Wolf-Henning Boehncke

The Impact of Acne’s Anatomical Variations on Social Perception 

/ Dermatologi / BestPractice Nordic

EADV 2022

Therapies for atopic dermatitis for special populations of patients

/ Dermatologi / April Armstrong

Severe atopic dermatitis in a pediatric population – Epidemiology, pathophysiology, and comorbidities

/ Onkologi / Ida Vittrup

Treatment of severe atopic dermatitis in a pediatric population

/ Dermatologi / Ida Vittrup

Bacterial resistance in Hidradenitis suppurativa: an update

/ Dermatologi / Thrasyvoulos Tzellos

When are hormonal agents indicated in acne?

/ Dermatologi / Trinidad Montero-Vilchez

A Nationwide E-health Platform for Atopic Dermatitis

/ Dermatologi / Laura von Kobyletzki

New study sheds light on the link between atopic dermatitis and academic achievement in childhood and youth

/ Dermatologi / Ida Vittrup

The Relevance of AI in Dermatology

/ Dermatologi / Hans Peter Soyer

Gender Equity in Dermatology

/ Dermatologi / Deirdre Murrell

Treatment of Severe Atopic Dermatitis (AD)

/ Dermatologi / Pedro Mendes Bastos

The role of JAK and BTK inhibitors in dermatology

/ Dermatologi / Deirdre Murrell

Does smoking really cause psoriasis?

/ Dermatologi / Charlotte Näslund Koch

Personalised Dosing – Patient-centered Dupilumab Dosing Regimen in AD

/ Dermatologi / Lotte Spekhorst

Short-term topical therapies and anti-IL-23 treatment updates for patients with nail psoriasis

/ Dermatologi / BestPractice Nordic

JAK inhibitors for patients with alopecia areata 

/ Dermatologi / BestPractice Nordic

A New Approach in Treating Patients with Alopecia Areata

/ Dermatologi / Bianca Maria Piraccini

Nail psoriasis: best management and new insights

/ Dermatologi / Bertrand Richert

Adalimumab Biosimilars in Psoriasis

/ Dermatologi / Nikolai Loft

EADV 2021

How to recognize and manage hair dye allergy

/ Dermatologi / Annarita Antelmi

Existing and upcoming small molecules in psoriasis treatment

/ Dermatologi / Enikö Sonkoly

Sjögren’s syndrome is a common disease, but unfortunately neglected

/ Dermatologi / Filippa Nyberg
Se oversigt

Vaccine hesitancy driven by safety concerns

/ Dermatologi / Álvaro González-Cantero

The risk of infections in psoriasis patients treated with biologics during the COVID-19 pandemic

/ Dermatologi / Lara van der Schoot / Juul van den Reek

Psoriasis has significant negative impact on quality of life

/ Dermatologi / Dimitrios Ioannides
Back to top